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1. Introduction
Tendon and ligament injuries are one of the most prevailing
health problems affecting the adult population worldwide.
From the 30 million musculoskeletal injuries reported every
year, over half are thought to involve these
tissues.[1–3] These injuries not only can
result in long-term pain, impaired func-
tion and disability, and so on, in reduced
quality of life, but also represent signifi-
cant economic costs: only in the United
States (US), 30 billion dollars are spent
on musculoskeletal injuries each year,
and only tendon/ligament injuries
alone represent about 45% of these
expenses.[1,3,4] Furthermore, these inju-
ries present a significant clinical challenge
as although spontaneous healing can
occur, it is a very slow process that fre-
quently results in the formation of a scar
tissue with low functionality.[2,3,5,6]
Due to this limited capability for self-
healing and the need for injured people
to regain their functionality in a timely
manner, surgical intervention is often
required.[2,7] Primary repairs involve the
use of sutures to reattach the injured ends.
However, this procedure is often ineffec-
tive, and it is not viable in case of extensive
damage. In such cases, autografts or allog-
rafts have been used to reconstruct the lost tissue, but these pres-
ent several disadvantages.[2,3,5,8,9] As a result of this market
demand, a variety of scaffolds have also been developed, some
to share loads with the injured tissue or with the used biological
graft and others to immediately replace the lost tissue and even
promote new tissue formation. However, the development of a
device that adequately mimics the mechanical performance of
the native tissue remains challenging.[2,4,7,9–12]
In an attempt to meet the demanding mechanical require-
ments of these tissues, most devices have been developed
using nondegradable polymers, such as poly(ethylene tere-
phthalate) (PET), due to their high tensile properties. However,
long-term problems due to fatigue, excessive laxity, or wear are
often reported, along with stress shielding of the new tissue
and lack of host tissue integration. As a result, these devices
have resulted in only minor or no improvement in clinical
outcomes.[2,4,7,12–16] The described shortcomings could poten-
tially be solved with the use of biodegradable materials.[13]
The most popular biodegradable polymers used in clinical,
including in implantable applications have been synthetic
aliphatic polyesters, such as polylactic acid (PLA), poly(glycolic
acid) (PGA), or poly(ε-caprolactone) (PCL), for example.
However, their poor mechanical properties restrict their suc-
cessful use in the long term in such demanding load-bearing
applications.[16,17]
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Tendon/ligament injuries are debilitating conditions that affect the life quality of a
great percentage of the adult population. Several challenges still have to be
addressed regarding the repair of these tissues, as current treatments show
limited success. The use of biocompatible and biodegradable polymeric scaffolds
potentially helps accomplish a complete and long-term functional repair but,
unfortunately, these materials lack adequate mechanical properties to be used in
such demanding applications. Graphene is a subject of interest for tissue-repair
applications due to its electrical conductivity and mechanical properties. If
incorporated adequately, it may significantly improve the physical properties of
the composite, even at small loadings. Furthermore, graphene presents a bio-
compatible surface that may enhance cell adhesion, proliferation and differen-
tiation and demonstrates promising outcomes in several in vitro and in vivo
biological applications. Therefore, herein, the potential of graphene materials for
the reinforcement of biodegradable polymers of interest for tendon/ligament
repair is explored. The effect of graphene on relevant features such as mechanical
properties, biodegradability, and biocompatibility is revised, to understand the
feasibility of these composites to fulfill the requirements associated with these
tissues and conclude how their applicability is extended to this field.
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Due to the present demand, research and engineering inter-
ests have been shifting from traditional polymeric materials to
polymer-based composites. These consist of a polymeric matrix
and reinforcement materials that, when combined, enable the
production of advanced materials with multifunctional require-
ments, enhanced properties, and remarkable performances.[18,19]
In this way, the integration of reinforcing materials may over-
come the limitations of a basic biodegradable polymeric device,
as it can form a composite with the combinatorial benefits of
each biomaterial, including biocompatibility, biodegradability,
and high mechanical properties.[20]
The use of different fillers for the enhancement of the
polymer’s properties has been well documented.[21–27] Yet,
graphene has been one of the most studied, especially regarding
the structural reinforcement of polymers, with dramatic changes
in mechanical properties being reported at very small load-
ings.[28–31] Furthermore, some authors report enhanced biocom-
patibility and biofunctionality in both in vitro and in vivo animal
studies when these materials are incorporated in scaffolds for
other tissue engineering applications, which makes this a very
interesting approach for the envisaged purpose.[32,33]
With the emergence of this new generation of high-
performance graphene-based materials, there could be now real
potential to overcome the limitations of current devices and
improve clinical outcomes of tendon and ligament repair. To
our knowledge, no document reviewing the potential of these
composite materials in this area exists. This will be our primary
focus. To set the stage, the tissues’ basic structure and properties
are presented, followed by the description of the most used
polymeric matrices for biomedical applications and the promi-
nent challenges of current strategies, providing foundation for
the need of novel approaches. Then, a brief section on graphene
as a reinforcing material is presented, and its effect on the
mechanical properties, biodegradability, and biocompatibility
of polymer composites is addressed, always focusing on the
establishment of a comparison with the envisaged application.
The article will close with some possibilities and challenges that
remain to be faced by future works.
2. Tendon and Ligament Tissues
To design scaffolds capable of properly repairing tendon and lig-
ament injuries, it is important to understand these tissues’ mor-
phology and mechanical behavior, as well as their mechanism of
injury and healing process.[34]
2.1. Structure and Function of Tendons and Ligaments
Tendons and ligaments are fibrous dense connective tissues.
Tendons bind muscle to bone while ligaments bind bone to
bone, and together, these tissues contribute to the transmission
of forces that allow body movement and stabilize the skele-
ton.[3,35–38] Although both tissues vary in size, shape, organiza-
tion, and anatomical location, their basic structure is quite
similar. They are characterized by the presence of an abundant
extracellular matrix (ECM), which is mainly composed of aligned
crimped collagen fibers embedded in a viscous ground sub-
stance, but a few embedded fibroblastic cells are also present,
being responsible for the production of the ECM components.
The most abundant fibrous component of the ECM is type I col-
lagen, which confers strength and stiffness to the tissue to resist
tension. A small fraction of elastin is also present to ensure tissue
extensibility and recover after stretching. The ground substance,
which consists of water, glycosaminoglycans, proteoglycans, and
glycoproteins, provides structural support and is essentially
responsible for the viscoelastic properties of the tissue.[1,3,39,40]
These tissues are organized in hierarchical structures of
increasing complexity (Figure 1). Tropocollagen is the basic struc-
tural unit of collagen molecules. These molecules are assembled
into fibrils, which consecutively assemble into fibers. These colla-
gen fibers are organized in a regular parallel manner and are asso-
ciated in fascicles (or fiber bundles), being involved by a loose
connective tissue sheath. The final tissue unit, composed of
grouped fascicles, is surrounded by another thin layer of connec-
tive tissue. These sheaths allow the fiber groups to glide on each
other in an almost frictionless manner and typically house the vas-
culature and innervation of the tendon/ligament unit. Ultimately,
some tissues are surrounded by another loose connective tissue
layer, which facilitates gliding on adjacent structures.[1,2,14,40,41]
Due to their composition and highly aligned organized struc-
ture, these tissues present a nonlinear and anisotropic response
to load, exhibiting high mechanical strength to withstand large
tensile forces, good flexibility, and viscoelasticity, meaning a
time-dependent and load history dependent behavior, exhibiting
stress relaxation, creep, and hysteresis, with the possibility to
resist the repeated cyclic strains typically experienced during
daily activities, without damage.[2,40,42–44] A typical stress–strain
curve of these tissues presents an initial “toe region” (2%
strain), in which the tissue accommodates to the applied load
by straightening its crimp pattern. This crimp acts as a buffering
system to shock, enabling the tissue to distend without sustain-
ing damage when a small elongation occurs. In case of further
elongation, the load is directly taken up by the completely
straightened collagen fibers, so the tissue enters in a linear rela-
tionship between load and strain, and the stiffness remains con-
stant as a function of elongation. Tendons and ligaments can be
strained to about 4%, returning to its original length and config-
uration without structural damage when unloaded, undergoing
elastic deformation. However, this resistive capability is not infi-
nite, and if this physiological limit is exceeded, the tissue loses its
crimp formation, becoming plastically deformed, and is vulner-
able to microscopic and macroscopic tearing.[2,3,37,40,43–45]
Although the mechanical properties of a tendon/ligament tis-
sue depend on its thickness and collagen content which, in turn,
vary with its function and with patient age and condition, in gen-
eral, these tissues present average values of the tensile strength
Figure 1. Structural hierarchy of a tendon.[16]
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of 50–150MPa, Young’s Modulus in the range of 1–2 GPa, an
average stiffness of 200 Nmm1, and ultimate strain values of
4–10%.[2,37,40,43]
2.2. Tendons and Ligaments Injury and Healing
Several pathologies can affect tendon and ligament tissues,
including degenerative disorders persistent over time, that arise
from collagen damage and cellular, vascular, and neurological
alterations, chronic overuse injuries resultant from previous
damage accumulation as a consequence of an imbalance between
the rate of microdamage occurrence and repair, and traumatic
acute injuries resultant of excessive mechanical loading.[3,46]
Nevertheless, statistical data suggest that the most frequently
damaged tissues are usually the ones that are exposed to the
highest stresses and repeated strains and the ones that are less
vascularized.[1,2] Achilles tendon is the most frequently ruptured
tendon in humans, with most ruptures occurring during
sports.[2,47,48] In Europe, an incidence rate of 37.3 cases per
100 000 individuals is reported.[2] Injuries to the glenohumeral
ligaments and the rotator cuff tendons of the shoulder joint have
also a high incidence, affecting more than 50% of individuals
older than 60 years old.[36] The reconstruction of the anterior cru-
ciate ligament (ACL) of the knee is one of the most commonly
performed orthopedic procedures, with around 250 000 surger-
ies being performed annually in the US.[49]
These tissues do not heal by tissue regeneration, but through a
very slow and often inefficient wound repair process instead, in
which the defect is filled with scar-like tissue.[2,9,50] This healing
process involves three sequential phases: inflammation, prolifer-
ation, and remodeling/maturation (Table 1). These phases can
overlap and the duration and efficiency of each one are depen-
dent on the location and severity of the injury, namely the tissue
loss degree, and on the age and condition of the patient.[1,2,50] In
the end, the composition, structural organization, and mechani-
cal properties of the tissue are not restored completely.[2,3,6,9,51]
The healed tissue presents poor viscoelasticity and is usually
weaker.[7,38] Indeed, as shown in Figure 2, some studies indicate
that tensile strength is restored only up to 80% of that of the
intact tissue after a year of remodeling.[37,43,44] As a result, it
presents inferior quality and functional activity, with high chan-
ces of a reoccurring rupture.[1,3,7,40]
3. Available Products for Tendon and Ligament
Repair and Replacement
Due to the limited ability for self-healing of tendons and liga-
ments, and the urgency of injured people to recover their func-
tionality, surgical intervention is often conducted.[2,7] Primary
repairs involve the use of sutures to reattach the injured ends.
However, the remaining tissue is often plastically deformed,
being incapable of sustaining the rigors of normal activities
and, as such, it may fail again. Furthermore, this approach is
not viable in the case of extensive tissue loss.[3,53] In such cases,
the use of autografts or allografts is often required for reconstruc-
tion surgery. Both alternatives present good initial mechanical
strength and allow integration within the host environment,
Table 1. Healing process of tendons and ligaments.[1,2,41,43,50–52]
Phase Duration Events
Inflammation Hours to a few days Hematoma formation.
Migration of inflammatory cells to the injury site and cleaning of necrotic materials by phagocytosis.
Release of vasoactive and chemotactic factors resulting in the formation of a vascular network and in the
recruitment of fibroblasts to initiate synthesis and deposition of ECM components, respectively.
Proliferation Weeks Synthesis and deposition of collagen type III and other ECM components.
Formation of thinner, poorly aligned fibrils with fewer crosslinks, giving rise to a disorganized fibrous tissue
The new tissue is highly cellular and contains large amounts of water.
The healing tissue remains mechanically weak and vulnerable to reinjury.
Remodeling/maturation Months to years Decrease in cellularity and matrix production.
The proportion of collagen type I increases.
Covalent bonding between collagen fibers increases. Both fibers and tenocytes align with the direction of stress,
resulting in the increase of tissue stiffness.
Fibrous tissue slowly transforms into scar-like tissues.
Figure 2. Evolution of the mechanical properties of a tendon during heal-
ing. Reproduced with permission.[2] Copright 2015, Springer Nature.
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but long-term rupture and excessive laxity are reported causes of
mechanical failure. Furthermore, material selection and dimen-
sioning can be problematic.[13] While autografts present disad-
vantages as limited availability and require additional surgery
which causes increased donor site morbidity and recovery time,
allografts present associated risks of immune rejection or disease
transmission.[2,5,8,9,14,37,54]
In an attempt to improve clinical outcomes where these stan-
dard repair strategies failed, several biological and synthetic scaf-
fold devices were developed (Table 2). These scaffolds were
produced to aid the restoration of normal function temporarily
or permanently. Most of these devices, mainly in the form of
patches, have been used for mechanical augmentation. They
are either used to provide immediate protection after a small tis-
sue tear by sharing mechanical stresses with the injured tissue,
allowing the original repair to proceed without suffering exces-
sive disruptive loads, or can be also combined with grafts to pro-
vide additional structural and mechanical support. Only a few
synthetic nondegradable devices have been used to fully replace
the tissue in case of extensive tissue loss, although no reliable
artificial tendon/ligament exists.[2,4,9,14,55,56]
3.1. Biological Scaffolds
Biological scaffolds consist of human or animal (equine, porcine,
and bovine) tissues, as pericardium, dermis, or small intestine
submucosa (SIS), which are processed to remove noncollagen
components that may cause host rejection, while preserving their
natural collagen structure. Because of their natural composition
and inherent porosity, these scaffolds can provide a chemically
and structurally instructive environment, providing a better and
faster host cell integration, thus having a marked effect on the
biology of healing events. However, the decellularization method
may present drawbacks, such as the presence of trace chemicals
which can be toxic to host cells. In addition, these scaffolds may
present variation in biocompatibility, undefined degradation
rates, and low mechanical properties, not being adequate to bear
substantial loads. Indeed, these scaffolds are often provided in
numerous layers to increase the mechanical properties of the
product in an attempt to realistically provide mechanical rein-
forcement to the repair site.[2,4,11,55–58]
3.2. Synthetic Scaffolds
Due to the low mechanical properties of biological scaffolds,
distinct synthetic scaffolds, manufactured from synthetic biode-
gradable and nonbiodegradable polymers, have been developed.
Besides the improved mechanical properties, synthetic polymers
also offer other advantages linked to large-scale manufacturing,
as they present a reliable source of raw materials along with low
immunogenic risks, are available in a wide variety of composi-
tions, and have an attractive processability, as they can be
Table 2. Commercially available products for tendon/ligament tissue repair.[2,4,11,14,55,56]
Category Product name ECM type ECM source Marketed by
(a) Extracellular-Matrix
Augmentation device Restore SIS Porcine Depuy Orthopaedics (USA)
CuffPatch SIS (cross-linked) Porcine Arthrotek (USA)
GraftJacket Dermis Human Wright Medical (USA)
ArthroFlex Dermis Human Arthrex (USA)
Conexa Dermis Porcine Tornier (USA)
TissueMend Dermis (fetal) Bovine Stryker Orthopaedics (USA)
Zimmer Collagen Repair Dermis (cross-linked) Porcine Zimmer (USA)
Bio-Blanket Dermis (cross-linked) Bovine Kensey Nash (USA)
OrthADAPT Bioimplant Pericardium (cross-linked) Equine Pegasus Biologics (USA)
Category Product name Material Marketed by
(b) Synthetic
Augmentation device SportMesh Poly(urethane urea) Biomimet Sports Medicine (USA)
X-Repair Poly-L-lactide Synthasome (USA)
Biomerix Patch Polycarbonate poly(urethaneurea) Biomerix (USA)
Gore-Tex Poly(tetrafluoroethylene) WL Gore and Associates (USA)
Kennedy Ligament Polypropylene DAW Industries, 3M (USA)
Leeds-Kuff Patch Polyester Neoligaments (UK)
Rota-Lok Polyester Neoligaments (UK)
AchilloCordPLUS Poly(ethylene terephthalate) Neoligaments (UK)
Prosthetic device OrthoCoupler Poly(ethylene terephthalate) Surgical Energetics (USA)
Lars Ligament Poly(ethylene terephthalate) Lars (France)
Leeds-Keio Poly(ethylene terephthalate) Neoligaments (UK)
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fabricated into different forms with lot-to-lot uniformity and pre-
dictable, controllable, and reproducible chemical, mechanical,
and degradation properties.[2,59–64] Furthermore, they can be
modified to solve problems as inflammatory side effects, hydro-
phobicity, and low cell adhesion.[65]
The first attempts that have been made for tendon and liga-
ment repair used nondegradable synthetic polymers such as
poly(ethylene terephthalate) (PET), used in devices as the Lars
Ligament (Lars, France) or the Leeds-Keio (Neoligaments, UK),
or polypropylene (PP) as in the Kennedy Ligament device
(DAW Industries, USA), due to the desired properties of excellent
tensile strength and biocompatibility. Most of these devices have
been used for mechanical augmentation and only a few were
intended for a permanent and complete replacement of the tissue.
Although these devices can initially replace the function or protect
the tissue that they are meant to repair, their inability to mimic the
native tissues’ mechanical behavior has led to failure under load-
ing and poor long-term results. As a result, some are no longer
used or even approved in some countries.[2,7,12–14,54,56] Tendon
and ligament tissues are continuously subjected to mechanical
loads during body movements, a demanding mechanical environ-
ment that restricts the successful application of most devices
alone. Common observed problems include device rupture due
to fatigue, excessive laxity from repeated elongation and creep,
and lack of durability related to wear and material degeneration,
along with inflammatory responses associated with the produced
wear debris. Stress shielding of the new formed tissue and limited
integration between the device and host tissue resulting in foreign
body reactions are also reported problems associated with the use
of these permanent devices.[2,14,54,56,66]
In view of these problems, it was logic to consider the use of
biodegradable polymers for the development of these devices.[17]
A few synthetic biodegradable augmentation devices exist, based
on poly(urethane urea) as the SportMesh patch (Biomimet Sports
Medicine, USA) and on poly(lactic acid) (PLA) as the X-Repair
patch (Synthasome, USA), for example, but are not intended
to replace the tissue structure or provide full mechanical strength
to support the repair.[67]
4. Designing Novel Tendon and Ligament
Tissue Substitutes: Application of Biodegradable
Matrices
Owing to the limitations associated with current approaches,
there has been an increasing market interest to develop a suitable
system that is able to promote/accelerate healing and re-establish
the native structure and functionality of an injured tendon/
ligament.[7,68–70]
An ideal scaffold meant for tendon and ligament repair should
be a biocompatible and biofunctional porous structure able to
promote and support tissue formation, without causing inflam-
mation or other reactions that may reduce or impede the healing
process or cause rejection by the body. It should present adequate
initial strength and mimic the nonlinear and viscoelastic
response of the native tissues, to adequately support the repair
and substitute the mechanical function of the diseased or dam-
aged tissue during the necessary healing period. This should be
accomplished while presenting a gradual degradation, during a
period that approximately matches the regrowth rate of the new
forming tissue, to concede room for new tissue growth and inte-
grate within the host environment and allow a controlled expo-
sure of the new tissue to the local mechanical environment,
avoiding a stress-shielding phenomenon.[2,35,63,64,71] It is well
demonstrated that controlled mechanical loads enhance the qual-
ity of the healing process, namely of repair and remodeling
events, by stimulating fibroblastic proliferation, differentiation,
collagen synthesis, and realignment, which is essential for a
homogeneous and functional repair.[39,45,72]
The selection of biomaterial is, therefore, a key element for the
development of tissue-repair devices.[64] Current biodegradable
biomaterials used in scaffold fabrication can be divided into cat-
egories of synthetic or naturally derived.[73]
Natural scaffolds include collagen, silk, hyaluronic acid, chito-
san, or fibrin, for example. Despite their higher biofunctionality
and biocompatibility, having the ability to be biologically recog-
nized and provide better environment to support the biological
events of tissue healing, these materials present limitations that
limit their application and evolution from a research stage to the
clinic, at least for now. These include their high induction of anti-
genic and immunogenic reactions, low mechanical properties,
not predictable or controlled degradation kinetics as their degra-
dation depends on availability and concentration of enzymes in
the implantation site, difficult processing, high cost, and variety
from batch to batch.[2,9,16,71,74]
On the other hand, synthetic polymers have been widely
applied in the medical field, which is essentially due to the afore-
mentioned advantages related to their properties and processabil-
ity. Polyesters such as poly(glycolic acid) (PGA), the stereoisomer
forms of poly(lactic acid), L-PLA and D-PLA, and their copolymer
poly(lactic-co-glycolide) (PLGA) and poly(ε-caprolactone) (PCL),
are among the most attractive biodegradable polymers used in
biomedical applications. These materials are already approved
by the Food and Drug Administration (FDA) for clinical use,
including in implantable applications, are considered biocompat-
ible and degrade by hydrolysis into nontoxic components that are
usually metabolized or excreted by the body.[62,64,65,75–77] Due to
these reasons, dozens of synthetic biodegradable medical devices
are commercially available, and every year more have been intro-
duced to the market. Some examples include fracture fixation
screws, sutures, dental orthopedic implants, stents, vascular
grafts, wound healing and surgical meshes, drug delivery, and
tissue augmentation.[65,75,78] The use of biodegradable polymers
for other applications is also being pursued relentlessly on a
research level.[17] These include scaffolds for tendon/ligament
direct replacement or tissue-engineering applications (Table 3).
Nevertheless, biodegradable synthetic polymers still present a
number of disadvantages that have to be addressed, as they have
limited the further application and evaluation of these materials
in animal and human trials.[17,88] For instance, these materials
are mechanically weaker than healthy musculoskeletal tissues
and, as such, do not reach the required in vivo strength.[16,17]
It is unquestionable that mechanical conditions are a key role
in material performance, especially in load-bearing applications,
and that the lack of mechanical compatibility between the device
and the native tissue interferes with the natural healing mecha-
nism and can thus represent a serious drawback for the damaged
tissue repair.[65] Also, it is difficult to achieve a balance between
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material degradability/loss of strength and the rate of tissue
healing and matrix production (Table 4). A gradual degradable
device, that still preserves at least half of its initial strength
for at least 3–6months implantation, is highly recommended
for adequate mechanical support in tendon/ligament repair.[92]
This class of materials undergoes a notable decrease in mechan-
ical strength after implantation[93] and are not able to maintain
tensile integrity during the necessary healing period, which
resulted in the device’s early failure.[68,88,94] Besides their low ten-
sile strength, they are also susceptible to creep and fatigue failure
under dynamic loading.[93,95] Moreover, polymers such as PLA or
PGA still present another challenge related to their acidic degra-
dation byproducts, which are known to reduce the local pH of
surrounding tissues, accelerate degradation, and induce inflam-
matory reactions.[13,65,93] The formation of blends, using differ-
ent polymers at adjustable concentrations, has been used in an
attempt to adjust mechanical properties and/or degradation rate
but still demonstrates limitations.[16,70]
Even though over the yearsmore information has become avail-
able, the effectiveness of a particular polymer for tendon and liga-
ment repair is still a matter of discussion. The scarce number of
studies that exist reviewing biodegradable devices report mixed
results and lack definitive conclusions, but it is acknowledged that
conventional single-component biodegradable polymer materials
Table 3. Examples of synthetic biodegradable scaffolds that have been studied for potential tendon/ligament repair strategies.
Biomaterial Type of study Findings References
PGA In vitro A PLLA scaffold maintained higher structural integrity with superior mechanical properties over
time, presenting also a higher cell account in vitro, when compared with a PGA and PLGA scaffold.
[79]
PLLA Anterior cruciate ligament
PLGA
PGA/PLA In vivo Neat PGA/PLA scaffold failed to form good-quality tendon tissue, which reached only 14% of
normal tendon’s strength after implantation, while the same scaffold seeded with adipose stem
cells was able to restore 60%.
[80]
Achilles tendon
PLLA In vitro and in vivo PLLA braided implants degraded faster in vivo than in vitro. 2.0 mm implants lost 69% of initial
tensile load in 46 weeks in in vitro degradation. In in vivo conditions, both 2.0 and 3.2 mm implants
retained only 3% and 4% of their initial tensile load-carrying capacity, respectively, after 48 weeks.
[81]
Anterior cruciate ligament
In vivo A cell seeded braided implant demonstrated excellent healing and regeneration capacity in vivo.
Tensile load decreased significantly at 12 weeks for unseeded scaffolds due to fatigue and low
collagen synthesis. This loss was less accentuated for seeded scaffolds, as the presence of cells




In vitro PLA braids show a nonlinear stress–strain behavior, with initial Young’s modulus and hysteresis
values in the range of those reported for tendons. After 12 months of hydrolytic degradation,




PLGA In vitro Observation of in vitro cell alignment and matrix formation along the aligned PLGA nanofibrous




In vivo After 12 weeks of implantation, the histology of Achilles tendons regenerated with cell seeded
(group I) and unseeded (group II) PLGA knitted scaffolds was similar to that of native tissue. The




PCL In vivo Electrospun PCL grafts were evaluated in vivo, with and without the addition of basic fibroblast
growth factor and human foreskin fibroblast cells. After 16 weeks, acellular grafts loaded with
growth factors achieved 58.8% of the stiffness and 40.7% of the load of native ACL, in opposition
with the scaffolds without added growth factors that only achieved 31.3% of the stiffness and
28.2% of peak load.
[86]
Anterior cruciate ligament
In vitro The produced electrospun PCL scaffolds demonstrated mechanical properties similar to those




Table 4. Properties of some synthetic polymers approved for use in
implantable medical devices in comparison with tendon/ligament














PGA 55–80 5–7 15–20 1–2 6–12
PLLA 45–70 2.7–3.5 5–10 3–6 >24
PLGA 55–80 2 3–10 1 1–12
PCL 10–35 0.4–0.6 300–500 >6 >24
T/L 50–150 1–2 4–10 – –
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cannot satisfy all the requirements for tendon/ligament repair. As
a result, no biodegradable replacement has been approved for clin-
ical use.[14,25,70,74,96,97] Thus, these biodegradable devices have to
be optimized to provide appropriate mechanical support during
the necessary period.[54]
As research for alternative ways continues, it is expected that, in
the future, novel strategies will lead to the design and production
of next-generation structures, mimic the mechanics of native
tendon/ligament tissues, and have the potential to lead to the com-
plete formation of a new, mechanically adequate natural tissue.[54]
Among these, the design and preparation of innovative polymer
composites is considered one of the most stimulating strategies.
The introduction of reinforcement materials into biocompatible
and biodegradable polymers could be an important possibility
to increase and modulate mechanical and degradation properties,
thus obtaining a material that fulfills several advanced functions at
once, overcoming the limitations of current devices.[25,60,70,98]
5. The Potential of Novel Graphene–Polymer
Composites for Tendon and Ligament Repair
The field of polymer composites has been growing, opening up
new possibilities in the development of advanced materials for
various modern applications, including in the biomedical and
biotechnological field, where conventional polymers cannot meet
all performance requirements.[22,99–102] These novel structures
can be defined as a multicomponent combination of two or more
materials, a discontinuous or dispersed phase called reinforce-
ment, and the polymeric matrix, a continuous phase surround-
ing the reinforcement, which, when combined, produce a final
composite that exhibits a combination of properties of their orig-
inal components, but may also acquire new properties, which are
not depicted by any of the constituents alone.[102–104]
A wide variety of reinforcements can be incorporated within a
polymer network to provide enhanced functionality, and the
choice depends on several factors such as cost, processability,
and the target properties.[21–26,102] Metal particles such as gold,
silver, iron, or copper, for example, may improve electrical, opti-
cal, magnetic, and electrochemical properties while metal-oxide
particles such as titanium dioxide or zinc oxide demonstrate
good properties to act as antibacterial agents.[22–26] Calcium phos-
phates and bioglass ceramic particles have been the most exten-
sively studied and used materials for bone tissue engineering
due to their osteoconductive nature.[22,25,100,101] On the other
hand, carbon-based materials such as carbon nanotubes
(CNTs) and graphene have been used in the production of poly-
mer composites as mechanical reinforcement agents.[21–26]
However, in comparison with CNTs, graphene presents advan-
tages such as lower production and purification costs and higher
surface-to-volume ratio.[28,30,105–107] Moreover, it has been shown
that, within the same loading, graphene-reinforced composites
may even outperform single-/multiwalled CNT-reinforced com-
posites in mechanical properties.[30,108,109] Furthermore, the
tubular morphology of CNTs, with nanometric diameter and a
high aspect ratio, appears as a potential risk to human health,
thus limiting their application in biomedical areas. Conversely,
graphene with its 2D morphology and nanometric thickness has
demonstrated good biocompatibility.[110]
This distinctive combination of properties makes graphene
one of the most promising materials to improve the performance
of conventional polymers, giving them the possibility to be used
in several fields for novel applications where their use is normally
restricted, including in tendon/ligament repair. As such, this
material will be the topic of further discussion in the next
sections.
5.1. Graphene as Reinforcement: Properties and Composite
Processing
Nowadays, graphene is considered the most attractive material in
the world of nanotechnology.[111] It is a 2D planar single layer of
sp2 hybridized carbon atoms, densely arranged in a hexagonal
lattice (Figure 3). These carbon atoms are bonded together by
strong covalent σ-bonds (C─C bonds), with an additional out-
of-plane π-bond, forming a conjugated C═C network and leading
to a bond length of 0.142 nm. Graphene has a thickness of
0.34 nm, which makes it the material with the smallest thickness
known.[105,112–116]
This unique planar arrangement and geometry of graphene,
with the strong carbon–carbon bonding, the aromatic structure,
and the presence of free π electrons, makes it a stable material
with unique characteristics, such as light weight, a high surface
area (2630m2g1), high elastic modulus (1 TPa), and high
tensile strength (130 10 GPa). Furthermore, graphene also
presents excellent thermal conductivity (5000Wm1 K1), high
electron mobility at room temperature (250 000 cm2 V1 s1), an
optical transmittance of 98%, and a tunable surface chemistry
that opens up many possibilities to obtain useful chemical func-
tionalization.[107,114,116–119]
A number of methods for graphene synthesis based on
bottom-up or top-down approaches have been emerging and
allow for numerous choices in terms of size, quality, and
cost.[31,111,115,116,119–121] Among them, the liquid-phase exfolia-
tion (LPE) of graphite has shown to be promising for the mass
production of graphene. Graphite’s low cost and availability,
along with the simplicity, speed, and high throughput of high-
quality graphene with good yield that is associated with this pro-
cess, make this approach very attractive among researchers and
Figure 3. Structural representation of graphene.
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promising for large-scale production.[31,116,122,123] However, the
production of defect-free monolayer graphene is still laborious
and costly for industrial applications. As a result, related materi-
als such as few-layer graphene (FLG) (2–10 layers of graphene),
ultrathin graphite (≥10 layers but less than 100 nm thick), and
graphene nanoplatelets (GNPs) (composed of single-layer and
few-layer graphene mixed with thicker graphite), which are com-
monly obtained following the LPE procedure without further iso-
lation steps, have been used instead.[109,121,124]
Graphene’s unique combination of properties indicate its
great potential for improving the thermal, electrical, andmechan-
ical properties of polymer composites. In particular, this material
has attracted enormous interest for the mechanical reinforce-
ment of polymers, as extraordinary improvements have been
reported in the presence of a variety of polymeric matrices, even
with a small amount of graphene.[28–31,125] As a result, the pres-
ent composite materials have led to a new generation of advanced
materials, opening up a wide range of novel applications in
several fields, such as in electronics, aerospace, automotive, con-
struction, and biomedical.[28,109,126–129]
A crucial step in polymer composites is the dispersion of the
reinforcement in the polymer.[109] A filler with a large surface
area-to-volume ratio in a well-dispersed state ensures a maxi-
mized interfacial area, which will enhance the load-transfer
ability of the mechanical force from the polymer to the reinforc-
ing phase and consequently, improve the properties of the
composite.[21,130–132] However, graphene, like all nanomaterials,
has a pronounced tendency to agglomerate in a polymer
matrix.[30,118,125] These nanoparticle agglomerates are unable
to interact efficiently with the polymeric matrix, prevent a uni-
form load transfer, and can even act as stress concentration
points, resulting in inferior properties or only mild performance
improvement, thus sacrificing graphene’s efficiency as
reinforcement.[21,118,125,132]
Large efforts have been concentrated on achieving a homoge-
neous and well-dispersed system via a compatibilization process,
which includes covalent or noncovalent functionalization of the
filler surface.[30,118,133] Covalent functionalization involves partial
modification of the graphene sp2 carbon lattice, leading to cova-
lent bonding of chemical functional groups to the graphene
surface. It may result in heteroatomic irregularity as well as intro-
duction of impurities and structural defects. This destruction of
graphene’s original structure can lead to impaired proper-
ties.[30,105,107,117,120,128] The most common example involves
the oxidation of graphene into graphene oxide (GO) to increase
hydrophilicity and facilitate dispersion and preparation of
composites. However, the presence of oxygen groups generates
structural defects that, in turn, affect strongly the mechanical
and electrical properties compared with graphene.[31,106,107,117]
Noncovalent modifications involve secondary interactions or
physical adsorption/wrapping of specific compounds on the gra-
phene surface. This approach generally relies on weak interac-
tions and preserves graphene’s structural integrity, imparting
no structural damage, as it does not affect the sp2 carbon hexag-
onal lattice of graphene and does not disturb the intrinsic prop-
erties of the material, being more advantageous from that point
of view.[30,105,107,117,120,128]
The ultimate properties of graphene–polymer composites also
depend on the composite processing conditions. The most
popular processes have been either solution mixing or melt
mixing. Solution mixing involves the dissolution of the polymer
and suspension of graphene in the same or miscible solvents,
followed by their mixing with the use of stirring, ultrasonication,
or shear mixing to disperse the particles homogeneously,
before removing the solvent. This approach is simple, with fast
fabrication and high control on component behavior, and very
effective for dispersing the filler in the matrix. However, chal-
lenges include finding common solvents, avoiding toxic and
non-ecofriendly organic solvents, which can be costly in large-
scale applications, difficulties in solvent removal, and common
reagglomeration during solvent evaporation. These observations
make apparent the challenges and limitations of graphene chem-
istry in solvent-mixing procedures and justify why this method
gets less attention for industrial applications. Melt mixing is a
solvent-free process that involves melting the polymer at an ade-
quate temperature and mixing graphene (in a powder form) at
high mechanical shear conditions. Compared with the previous
method, this approach is simpler, faster, economically advanta-
geous, environmentally friendly, and more compatible with
many current industrial productions. However, the viscosity of
the polymer may result in less-effective dispersion of the filler
at higher loadings.[21,31,107,121,128,134]
5.2. Graphene–Polymer Composites for Tendon/Ligament
Repair
Graphene and graphene-based materials have attracted interest
in several biomedical applications, including biosensing and bio-
imaging, drug delivery systems and gene therapy, photothermal
therapy, and as antibacterial agents.[114,121,135–138] Methodologies
for their incorporation in polymers for different tissue-
engineering strategies (e.g., cardiac, neural, cartilage, bone, mus-
culoskeletal tissue, skin) have also been under study, majorly
focusing on its effect as structural reinforcement in hydrogels,
films, fibers, and other tissue-engineering scaffolds, to optimize
the primary mechanical properties of the neat materials that are
currently being used for this purpose, which are often below the
requirements.[32,33,110,121,136] These scaffolds can even exhibit
other functional properties of interest, such as enhanced electri-
cal conductivity. It is acknowledged that electrical conductivity
can be a useful tool to direct cell growth, enhance cellular
activities, and stimulate the tissue-healing process.[106,110,136]
Furthermore, graphene and graphene-related materials are
considered exceptional substrates for promoting the adhesion,
proliferation, and differentiation of various cell types and thus,
facilitating the tissue-reforming process.[33]
The addition of graphene and graphene-based materials into
biodegradable matrices may be an interesting strategy to improve
the performance of a tendon/ligament biodegradable scaffold. The
goal is to obtain properties comparable with the traditionally used
nondegradable polymers and the native tissues, to match the
required properties to provide the necessary support during the
repair process. However, to effectively understand the impact that
graphenemay have in themodulation of tendon/ligament scaffold
properties and its potential for the repair of these tissues, its effect
on several parameters should be carefully evaluated. Namely, the
mechanical properties, biodegradability, and biocompatibility of
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the matrix are of great importance in determining the success of
the final outcome and may be sensitive to filler incorporation.
Therefore, the effect of these materials upon the behavior of
the most interesting and researched biodegradable polymers for
tendon and ligament repair will be reviewed next.
5.2.1. Effect on Mechanical Properties
Tensile Mechanical Properties: Most of the work on graphene/
polymer composites is aimed at improving the mechanical
properties of the composite material. The evaluation of the rein-
forcing capacity is usually accomplished by the analysis of the
stress–strain curves obtained by tensile testing. Hence, most
research studies focus on the mechanical properties of graphene-
filled polymer composites, revealing changes in tensile strength,
elastic modulus, and elongation at break and toughness, as a
function of filler loading.[29,31,109]
However, despite all the research conducted in this area, sev-
eral problems have to be resolved and the full potential of these
composites is still to be reached. The mechanical properties of
these composites depend on several parameters such as the phys-
ical structure of graphene, its chemical characteristics, the com-
posite preparation method, the dispersion of the nanoparticles
in the matrix, and the final nanoparticle–matrix interactions.
Although it was reported that the mechanical properties of the
composite may be remarkably increased even at very small filler
loadings, in other cases, deterioration of the properties is
observed. The polymer’s brittleness can significantly increase
in the presence of nanoparticle agglomerates, which are known
to act as failure points. The presence of a considerable concen-
tration of nanoparticle agglomerates justifies the observation of
tensile strength saturation or even decrease while increasing
nanoparticle loading. Typically, elongation at break follows a sim-
ilar trend and decreases extensively at high nanoparticle loads,
whereas the tensile modulus usually increases with increasing
filler content, being less susceptible to the presence of agglom-
erates and responding to the overall composition. However, it
should be noted that these properties do not necessarily decrease
with the introduction of graphene. Numerous authors have
reported strength and ductility improvements as a result of
improved dispersion, especially at low filler contents.[31] The
introduction of these fillers may also affect the polymer’s crystal-
linity, as graphene may act as a nucleating agent during crystalli-
zation and enhance the degree and rate of the crystallization
process of the composite, which may increase the material’s
strength but also restricts the movement of the polymer chains,
making it brittle.[21,139] Furthermore, as previously mentioned,
the presence of functional groups may enable stronger interac-
tions between the filler and the matrix, and so, it may result in a
higher reinforcing ability. As such, functionalized materials are
often preferred over neat graphene-based materials for mechani-
cal reinforcement.[31,107]
Table 5 shows results reported in the literature on themechan-
ical properties of the previously mentioned biodegradable syn-
thetic polymers, reinforced with different graphene-based
materials. Only a few examples will be described in detail.
Li et al.[141] prepared PLA/graphene composite films by sol-
vent mixing and verified a continuous increase in tensile
strength with increasing graphene loading from 0 to 1.0 wt%,
reporting a maximum increase of 39.57% for 1.0 wt%. However,
both elongation at break and toughness values decreased with
increasing graphene content, meaning that although the intro-
duction of graphene resulted in increased polymer strength,
it also restricted the movement of the polymer chains, increasing
its brittleness. Other authors reported similar results, such as
Tong et al.[159]. Scaffaro et al.,[148] and Narimissa et al.,[149]
who also verified an increase in composite stiffness to the detri-
ment of its tensile strength and elongation at break. The addition
of the reinforcement material leads to weak regions in the matrix-
filler system, along with embrittlement. Pinto et al.[142] prepared
PLA/GO and PLA/GNP composite films by solvent mixing,
reporting a maximum in mechanical performance for only
0.4 wt% loading of the two graphene-based materials tested, with
an increase of 15% in tensile strength and 85% in Young’s mod-
ulus, decreasing at higher loadings for the final solvent-free
films. In this case, elongation at break measurements did not
show a well-defined dependence on loading and seemed not
to be considerably affected by filler addition. Similar behavior
was reported by Gonçalves et al.[147] who prepared biocompatible
PLA/GNP films by melt mixing, reporting a maximum mechan-
ical performance at only 0.25 wt% loading, with a 20% increase
in tensile strength, 12% increase in Young’s modulus, and
16% increase in toughness (Figure 4). However, a decrease in
mechanical performance at higher loadings was observed, which
was attributed to increased nanoparticle agglomeration that
introduced defects in the polymer matrix. Again, no significant
differences were observed between PLA and composites regard-
ing elongation at break.
Li et al.[143] prepared PLLA-based composites by solvent
mixing using GO and functionalized GO-g-PLLA, to study the
effectiveness of functionalization in the final properties of the
composite. At 0.5 wt% loading, the authors reported both
increase in strength and ductility, namely an increase of 51.4%
in tensile strength and of 37.1% in elongation at break in
PLA/GO composites and an increase of 105.7% in tensile
strength and of 122.8% in elongation at break for functionalized
GO composites, which effectively illustrated the benefits of a
compatibilization process in aiding the filler dispersion and
interfacial interactions with the matrix.
The same trends were observed for composites with other
polymers. Yoon et al.[152] prepared PLGA/GO composites by
solution mixing, followed by electrospinning, with 1 and 2 wt%
filler loading. It was at maximum loading that the authors
observed the highest reinforcement effect, reporting an impres-
sive increase in 36.4–74.6MPa in tensile modulus, 2.1–3.4MPa
in ultimate tensile stress, and 9.5–30.7% in ultimate strain.
Similarly, Mohammadi et al.[154] prepared PCL composites with
different GO contents of 0.5, 1, and 2 wt% and it was also at max-
imum loading that the authors observed significant enhance-
ment of properties. The pure PCL had a tensile strength of
1.61MPa, an elongation of 122%, and a Young’s modulus of
7.01MPa and when 2% GO was added, a considerable increase
was observed in tensile strength to 3.50MPa, elongation to
131%, and Young’s modulus to 15.15MPa. Lastly, Ramazani
et al.[156] incorporated GO and reduced GO at 0.1, 0.5, and
1 wt% into PCL, and studied the effect of both particles on
the mechanical properties of the composite. The authors
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reported an increase of 160% and 103% in tensile strength and
elastic modulus, respectively, for PCL/GO electrospun nanofiber
scaffolds, and of 304% and 163% for PCL/reduced GO scaffolds,
for only 0.1 wt% loading. The results suggested that smaller
loadings were more effective for composite reinforcement, which
may be due to good filler dispersion and higher achievable sur-
face area interaction with the molecular chains of the polymer. At
higher loadings, the distance between the graphene sheets
Figure 4. Effect of increasing filler content on mechanical properties of PLA/GNP-C composites a) Young’s modulus; b) tensile strength; c) toughness.
Reproduced with permission.[147] Copright 2018, John Wiley and Sons.
Table 5. Mechanical properties of biodegradable graphene–polymer composites. σ, tensile strength; E, Young’s modulus; ε, elongation at break; NR, not
reported; f, functionalized; DDAB, didodecyldimethylammonium bromide; PSS, Poly(sodium 4-styrenesulfonate).
Matrix Mixing method Graphene type Loading [wt%] Mechanical properties Ref.
PLA Solution mixing Graphene nanosheets (GNS) 0.2 σ: " 26%; E: " 18% [140]
Exfoliated graphene 1 σ: " 39.57%; ε: # (NR) [141]
GNPs and GO 0.4 σ: " 15%; E: " 85%; ε: ¼ [142]
GO 0.5 σ: " 51.4%; ε: " 37.1% [143]
GO-g-PLLA (f ) σ: " 105.7%¸ ε: "122.8%
Melt mixing GO 0.2 σ: " 8.8%; E: ¼; ε: # 54.2% [144]
DDAB–GO (f ) σ: " 6.3%; E: # 23.3%; ε: " 2659.3%
Exfoliated graphene 0.2 σ: " 6.1%; E: " 6.5%; ε: # 9.5% [145]
Graphene 0.08 σ: " 35% [146]
GNP 0.25 σ: " 20%; E: " 12%; ε: ¼ [147]
GNP 5 σ: # 1.9%; E: " 39.4%; ε: # 36.9% [148]
Nanographite platelets 3 σ: # (NR); E: " 135%; ε: # (NR) [149]
Small GNPs 5 σ: " 16%; E: " 10%; ε: # 3% [150]
Large GNPs σ: " 41%; E: " 24%; ε: # 60%
PLGA Solution mixing GO 5 σ: " 153.5%; E:" 372.9%; ε:# 53.4% [151]
GO 2 σ: " 61.9%; E:"104.9%; ε: " 223.2% [152]
PCL Solution mixing PSS–graphene nanosheets (f ) 0.5 σ: "12.8%; E: " 11.8%¸ ε: " 13.2% [153]
GO 2 σ: " 117.4%; E: " 116.1%; ε: " 7.4% [154]
GO nanoplatelets 0.3 σ: " 95%; E: " 66% [155]
GO 0.1 σ: " 160%; E: " 103%; [156]
Reduced GO σ: " 304%; E: " 163%
GO (stirred) 1 σ: " 8.3%; E: " 20.9%; ε: #13.9% [157]
GO (ultrasonicated) σ: " 14.1%; E: " 37.4% ; ε: # 7.2%
Graphite (stirred) σ: " 5.1%; E: " 14.5% ; ε: # 14.7%
Graphene 1 σ: " 138.4%; E: " 275% [158]
2 σ: " 54.1%; E: " 301.8%
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decreased, resulting in a higher tendency to restack, which
impeded a uniform filler dispersion and an efficient load trans-
fer, decreasing the efficiency of the mechanical reinforcement
effect. These results are in agreement with what is described
in the literature.
The properties described show clear dependence on the type,
dispersion, and composition of graphene and its derivates.
Therefore, careful consideration must be set in the choice of gra-
phene characteristics and composite processing conditions to
obtain the best possible reinforcement effect and composite per-
formance. Nevertheless, the presented results are very encourag-
ing, with substantial improvements in mechanical properties
being reported, especially at low loadings. It is, thus, demon-
strated that graphene may be of great advantage to improve
the properties of biodegradable polymers. As such, the resultant
composite materials have considerable potential for the develop-
ment of high-performance scaffold devices with adequate archi-
tectures that match appropriately the required mechanical
properties and performance for specific tendon/ligament tissues,
giving, in this way, an opportunity to these biodegradable poly-
mers to be applied where their use has been restricted. However,
improvements in tensile properties are only one step, as other
characteristics should also be accessed.
Other Mechanical Properties: Besides the increase in tensile
properties, improvements in creep, fatigue, and wear life of
graphene–polymer composites have been reported.
Bustillos et al.[160] evaluated the creep behavior of PLA–
graphene composites at varying initial loading levels. The authors
reported significant improvement in creep resistance of PLA–
graphene composites in comparison with the neat polymer.
Even at high loading levels, the addition of graphene decreased
the creep displacement by 20.5%. Charitos et al.[161] also reported
increased creep resistance of PLA/GO (1wt%) in comparison
with the neat polymer. Similarly, Ramazani et al.[162] also reported
an increase in creep resistance of 24% and 41% for PCL/GO and
PCL/reduced GO composites (0.1 wt%), respectively. This
enhanced creep resistance can be attributed to the restriction of
polymeric chains by graphene, resulting in an effective distribu-
tion of load to the graphene reinforcement, preventing further
deformation of the polymer network and consequently, resulting
in higher resistance to plastic deformation.[160] Similar behavior
has been observed in tensile creep testing of other polymer/
graphene composites.[163–165]
Increased wear resistance and fatigue life have also been
observed with graphene incorporation. Bustillos et al.[160] evalu-
ated the wear resistance of PLA–graphene composites, reporting
an increase in 14% relative to the neat polymer. The authors
concluded that graphene’s mechanical strength may have con-
tributed to improved wear resistance.[160] Enhanced wear resis-
tance of other graphene-based composites has been reported
by other authors.[166–170] Vieira et al.[171] concluded that the addi-
tion of GNP (2 wt%) improves the fatigue behavior of PLA at high
strain rates. Bortz et al.[172] observed significant enhancement in
fatigue life of GO/epoxy composites (0.5 wt%), in comparison
with the neat polymer. Mean life at the highest comparable stress
level was 420% greater than that of the control. Improvements
at lower stresses were even more remarkable, about 1580%.
Other authors have also observed this positive effect in fatigue
life.[173–175] It is possible that the addition of graphene may also
suppress the formation and expansion of microcracks during
cyclic loading, enhancing the lifespan of the composites.[174]
Considering the viscoelastic nature of native tendon and liga-
ment tissues, it is important that the scaffold structure presents a
similar nonlinear viscoelastic response to loading, which is
exhibited by polymer materials, including biodegradable poly-
mers.[171] However, devices for tissue repair are under long-term
and repeated loading, so these must also demonstrate good
resistance to creep and fatigue, to remain working and provide
adequate support during the necessary healing period. The
described enhanced creep and wear resistance, along with
improvements in the fatigue life of graphene-based polymeric
composites, are of extreme importance regarding the desired
application. As stated earlier, common problems associated with
the use of current commercially available scaffolds include device
failure due to fatigue, excessive laxity due to repeated elongation
and creep, and lack of durability related to wear. As demon-
strated, the application of graphene in biodegradable polymeric
scaffolds has the potential to improve their lifetime performance
and as such may solve or at least minimize the described
problems.
5.2.2. Effect on Biodegradability
To be able to use biodegradable polymers in durable applications,
it is important to understand the impact of the surrounding con-
ditions on their degradation properties, predict their mean life, as
well as improve their resistance to degradation, as even if the
initial performance meets the requirements for the target appli-
cation, their durability in certain conditions may become inade-
quate for the desired time of use.[176]
Biodegradable polyesters are generally degraded by hydrolysis
of the ester linkages, a phenomenon that takes place via a diffu-
sion reaction mechanism in which water or other fluids (e.g.,
body fluids) penetrate the matrix and cause the breakdown of
chemical bonds present in the polymer backbone, leading to
polymer erosion, which decreases its molecular weight and
can even result in the formation of acidic byproducts as previ-
ously explained, which can further induce an enhanced water
affinity and autocatalyze the reaction, promoting the degradation
process.[13,64,98,176] Recently, it has been reported that the inhibi-
tion of the diffusion kinetics can be achieved by intercalating gra-
phene in the polymer matrix, which, due to its hydrophobicity,
creates a physical barrier that hinders the penetration of water,
thus delaying the onset of hydrolysis.[176] Also, as previously
stated, the addition of graphene materials may increase the poly-
mer’s crystallinity.[176,177] It is well established that the rate of
water diffusion can be controlled, in a certain degree, by modi-
fying the material’s crystallinity. If the polymer’s crystallinity
increases, the degradation rate decreases, as it is easier to
degrade the amorphous part of the matrix as the higher rate
of water uptake occurs in the free volume regions than in the
crystalline ones.[63,176,178] Nevertheless, although it has been
reported that the particles may act as nucleating agents at low
concentrations, at higher concentrations, their interactions with
the polymer may affect the crystallinity adversely.[177]
Girdthep et al.[179] prepared PLLA/graphene composites by
solution mixing and conducted hydrolytic degradation assays
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in sodium hydroxide aqueous solution (initial pH¼ 8) at 30 C.
At the end of the study (30 days), the authors observed a higher
hydrolysis resistance by the PLLA-based composites in the pres-
ence of graphene in comparison with the neat sample. Therefore,
graphene behaved as a hydrolysis-resistant agent. Furthermore,
graphene did not hinder polymer chain mobility and rearrange-
ment during hydrolysis. Pinto et al.[180] incorporated two grades
of GNP-M and GNP-C in PLA by melt mixing (0.25 wt%) and
subjected the composites to hydrolytic degradation for 6months,
in phosphate-buffered saline (PBS) at 37 C, conducting tensile
and creep characterization after that period to assess the extent to
which the materials were able to maintain their mechanical prop-
erties and performance. Although no significant changes were
observed in Young’s modulus, a decrease in tensile strength,
elongation at break, and toughness was higher for PLA
(2.6, 2.5, and 10-fold, respectively), compared with PLA/GNP-M
(1.6, 1.8, and 3.3 fold) and PLA/GNP-C (1.4, 1.4, and 1.7 fold).
Creep results (Figure 5) showed that neat PLA presented a higher
permanent creep strain in comparison with the non-degraded
PLA, whereas both composites displayed behaviors equivalent
to the nondegraded samples. Furthermore, after ten creep/
recovery cycles, the degraded neat polymer samples ruptured
after four cycles, showing a very intense cumulative increase
in permanent creep strain, whereas the composites did not rup-
ture after the tenth cycle, presenting only a slight increase in per-
manent creep strain. Therefore, the authors concluded that GNP
fillers were able to both improve the mechanical properties of
PLA and reduced the decay of its mechanical performance dur-
ing degradation while also being able to significantly counteract
the negative effect of biodegradation on PLA’s creep stability,
attributing this remarkable effect to the fillers’ interaction with
the matrix.
However, this capacity may be dependent on the type of
graphene-based material used. Jeong et al.[181] prepared PLA/GO
and PLA/lipophilized-GO functionalized with octadecylamine
(0.1 and 0.5 wt%) composites by solution mixing and conducted
hydrolytic degradation studies in a NaHCO3/NaOH buffer solu-
tion (pH¼ 10.7), at 60 C, to analyze the effect of both fillers in
the polymer’s degradation rate. After 40 days, a high weight loss
was verified for neat PLA of 35.8%, of 38.4% and 48.1% for
PLA/GO, and of 31.4% and 17.2% for PLA/functionalized
GO, for 0.1 and 0.5 wt%, respectively. According to the authors’
remarks, while the hydrophilicity of GO might have accelerated
water permeation, the hydrophobic nature of the functionalized
filler might have acted as a barrier for water permeation effi-
ciently to reduce the hydrolytic degradation rate of PLA, so por-
tions of the polymer remained protected for a longer period,
providing enhanced hydrolytic stability along time. Mohammadi
et al.[154] also draw the same conclusions. The authors studied the
effect of different GO contents (from 0.5 to 2 wt%) on the deg-
radation behavior of electrospun PCL composite nanofibers, in a
NaOH solution at 37 C. In their degraded state, PCL, PCL/GO
0.5, 1, and 2 wt% showed 45%, 55%, 57%, and 69% mass loss,
respectively. Clearly, by increasing GO loading, the degradation
rate of the PCL scaffolds was also increased. According to the
authors’ conclusions, the presence of GO sheets may have
increased the density of the hydrophilic groups in the polymer
chains and the global hydrophilicity of the structure, which
resulted in more water adsorptions and hydration of PCL chains,
resulting in faster degradation. These works suggest that the
hydrophobicity of the graphene fillers may be an important factor
to limit water accessibility and retard the hydrolysis of these poly-
esters, whereas on the contrary, its hydrophilic counterpart, GO,
may induce the opposite effect.
However, other works contradict these findings. Park et al.,[151]
for example, conducted in vitro degradation studies of PLGA/GO
composites with different wt% in a phosphate buffer (pH 7.4)
solution at 37 C, demonstrating enhanced hydrolysis resistance
in PLGA/GO composites in comparison with the neat polymer
(Figure 6). The highest weight loss was registered for PLGA
and, then decreased with increasing GO content. The authors also
noticed decreasing pH values in the test medium with degrada-
tion time (from 7.4 to 3.7) in PLGA polymer, which confirmed the
release of acidic materials from the polymer and retention of deg-
radation products in the solution, leading to pH decrease. The pH
changes were also detected for PLGA/GO composites but lower
compared with the pristine polymer, meaning that less acidic
byproducts were released into the medium.
Again, filler-type and processing conditions may contribute to
the existing variability of results (Figure 7). One factor that is not
always considered is the quality of the interface. A better inter-
action between the polymer and graphene can also contribute to a
decrease in the degradation rate.[178] On the contrary, weak inter-
actions can create gaps between the reinforcement and matrix,
which facilitate the penetration of water molecules into the mate-
rial, triggering degradation.[182] Furthermore, recent conclusions
point that the hydrophobicity of graphene is thickness
Figure 5. Creep-relaxation curves for a) PLA and b) PLA/GNP-M and c) PLA/GNP-C composites before (0 M) and after 6 months (6 M) degradation.
Reproduced with permission.[180] Copyrigyt 2016, Elsevier.
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dependent, with single-layer graphene exhibiting significantly
higher hydrophilicity than its thicker counterparts.[183]
Degradation properties are of crucial importance in biomate-
rial selection and design in tendon and ligament repair strate-
gies, as the in vivo degradation behavior can have a crucial
impact on the long-term mechanical performance of the struc-
ture and on a range of processes such as tissue healing and host
response, as previously explained.[25] However, one of the major
problems regarding current biodegradable devices is that their
mechanical performance cannot be maintained over the neces-
sary healing time, as they begin to degrade and lose strength
earlier than desirable. Through the application of graphene mate-
rials, it may thus be possible to retard hydrolysis and slow down
the degradation rate of these polymers, while increasing and pre-
serving their mechanical properties for longer periods of time.
Consequently, the release of acidic byproducts that autocatalyzes
the degradation process and causes adverse reactions is also
minimized. Furthermore, with this approach, the scaffold perfor-
mance may be extended without compromising stress transfer to
the new forming tissue, as although hydrolytic stability increases,
degradation still occurs, although in a minor extent.
5.2.3. Effect on Biocompatibility
Although graphene and graphene-based materials are being
researched for various biomedical applications, before being con-
sidered for use in biomaterials, the in vitro and in vivo evaluation
of their biocompatibility and cytotoxicity is of vital importance.[29]
However, compared with simpler molecules, where only concen-
tration and exposure type and time are the main toxicological
criteria to consider, due to the variability and inhomogeneity
of graphene samples, the interactions between these materials
with cells, biomolecules, and tissues are various and different
and thus require the evaluation of a higher number of fac-
tors.[119,136,184] These materials may exhibit dose, size, and
shape-dependent cytotoxicity.[110,119,136,185] It is reported that
graphene materials do not present in vitro cytotoxicity at a low
concentration, exhibiting a low negative influence on cell
morphology, viability, and/or proliferation.[110] It is also acknowl-
edged that diverse shapes contribute to differences in cytotoxicity
reports. Flat shapes are expected to have minor interactions
with cellular membranes and so exhibit less toxicity effects.
Indeed, one of the main reasons concerning the application of
CNTs in implantable biomedical applications was their tubular
shape, which promoted penetration of membranes, resulting
in cytotoxicity.[110,186] Third, size may also play an important role
on biocompatibility although the reported conclusions are still
debatable. Some authors report a higher cellular uptake and tox-
icity for smaller particles, whereas others report nano-sized gra-
phene materials to be much safer.[110,186,187] Furthermore, the
biocompatibility of these materials may also be dependent on
their chemical composition. According to literature, functional-
ized graphene materials present improved biocompatibility by
improving hydrophilicity and providing potential cell adhesion
sites, like hydroxyl groups.[110,136,185,186]
Figure 6. a) pH changes during degradation of PLGA/GO composites; b) weight loss as a function of hydrolysis time of PLGA/GO composites.
Reproduced with permission.[151] Copyrigyt 2014, John Wiley and Sons.
Figure 7. Weight loss (%) results derived from different in vitro degrada-
tion studies of polymer–composite systems.
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Nevertheless, it has been demonstrated that the possibility of a
toxic effect of the fillers is even more diminished when incorpo-
rated in biomaterials.[184] Graphene-based polymer composites
have been investigated as scaffolds for cell culture and tissue
engineering and have exhibited negligible harmful effects.
Most of available in vitro studies report that graphene and its
derivates are biocompatible, do not tend to decrease metabolic
activity, and present low cytotoxicity with various cell types,
including human mesenchymal stem cells, human osteoblasts,
and fibroblasts.[33,121,135] Indeed, many studies have pointed
out that graphene and graphene-based materials are excellent
substrates for promoting proper cell adhesion, proliferation,
and differentiation, as well as enhancing cell activities, in this
context.[33,110,135,188]
Gonçalves et al.[147] studied the biocompatibility of PLA/GNPs
films (0.25 wt%) by culturing human foreskin fibroblasts
(HFF-1) at the material’s surface. The incorporation of GNPs
did not affect the cells’ metabolic activity or morphology, in com-
parison with the neat polymer. As such, the incorporation of GNPs
had no negative impact on cell growth. The authors concluded that
the low filler loading, together with the platelets being well encap-
sulated in the polymer, were the reasons for the lack of toxicity
observed. Pinto et al. went further[180] by evaluating the biocom-
patibility of the degradation products of PLA/GNP (GNP-M and
GNP-C) composites (0.25 wt%) after 6months of hydrolytic deg-
radation. When in contact with the degradation products, HFF-1
cells presented low cell death and typical “spindle”-like shapes. So
the authors concluded that no toxic products were released in that
period. This is relevant considering that long-term biocompatibil-
ity must be assured for safe polymer/graphene composite
implantation. Pinto et al.[15] also reported PLA/GNP (2wt%) to
be biocompatible, both in vitro and in vivo. In vitro findings using
HFF-1 cells showed that the presence of GNPs in the PLA matrix
did not affect the viability or proliferation of seeded cells. The com-
posites registered values above 99% for cellular metabolic activity
(normalized to PLA control), and were able to support cell prolif-
eration, with values up to 136% being determined in comparison
to PLA. In their in vivo study, after 2 weeks of subcutaneous
implantation in a mouse model, the implantation site did not
reveal any signs of severe inflammation and the granulation tissue
of the implant area presented good tissue remodeling, a sign of a
healthy healing process.
In two different works, Yoon et al.[152,189] demonstrated
enhanced biocompatibility of PLGA/GO composites with two
different cell lines, HeLa and neuronal PC 12 cells, due to the
addition of GO. Neuronal cells on PLGA/GO (2 wt%) composite
nanofibers [152] exhibited enhanced neurite outgrowth and
branching compared with cells in the composites with the lowest
GO concentration (1 wt%) and in the neat PLGA nanofibers.
After 2 days of culture, cell proliferation and viability data showed
significant differences in metabolic activities, again, being better
for PLGA/GO (2 wt%) compared other conditions. Similar
results were obtained for HeLa cells on PLGA/GO composite
films.[189] Significant differences in metabolic activities for differ-
ent samples were found, with better results reported for the com-
posite with the highest GO concentration (2 wt%). Also, HeLa
cells were found adhered and well spread on the surface of
PLGA/GO (2 wt%), illustrating their good affinity with the sub-
strate, with a well-preserved cell membrane, compared with the
cells on PLGA and PLGA/GO (1 wt%). Esrafilzadeh et al.[190] also
demonstrated the suitability of PLGA/graphene fibers as a bio-
compatible, cell-supportive substrate by reporting good attach-
ment, growth, and proliferation of skeletal muscle myoblast
(C2C12) cells over the cell culture period. These cells were seen
to adhere and elongate along the longitudinal direction of the
fibers. Also, cells proliferated to cover the entire fibers’ surface
within 3 days of culture.
Su et al.[191] also proved the effectiveness of a GO-doped PLGA
nanofibrous membrane for the regeneration of tendon to bone
enthesis. An in vitro evaluation demonstrated that the composite
scaffolds accelerated the proliferation of bone marrow stromal
cells and promoted their osteogenic differentiation (Figure 8a).
Quantitative analysis revealed that the ALP activity of BMSCs cul-
tured on the PLGA and PLGA/GO membranes was higher
than that on the blank control (BC) group, and this increase was
higher for the composite (after 7 and 14 days). Furthermore, an
in vivo study in a rabbit model further demonstrated that by
applying the composite membrane to the gap between a rotator
cuff tendon and the bone, the healing of the enthesis was pro-
moted. The PLGA/GOmembrane revealed significant capacity to
support new bone and cartilage formation at the tendon–bone
interface. At 8 and 12 weeks of the study, the control group
was filled with fibrous scar tissue and did not present new carti-
lage regeneration. A few chondrocytes and some new bone were
found at the interface in the case of PLGA, whereas a larger new
cartilage formation was observed in the PLGA/GO group
(Figure 8b). Furthermore, at all time points, the PLGA/GO com-
posite membrane demonstrated the significantly improved pro-
duction of type I collagen at the healing site in comparison with
the other groups, and biomechanical properties were also
improved in comparison with the PLGA and control groups,
which emphasized the significance of GO during the process
of tendon–bone healing.
Murray et al.[192] synthesized PCL/rGO scaffolds by the ring-
opening polymerization of ε-caprolactone under the exposure of
GO nanosheets. After culturing L929 fibroblasts on their
surface, the authors observed good cell adhesion and prolifera-
tion, forming good focal adhesions, and covering the entire
scaffold. The cells grew with normal morphology and cell density
increased over the culture period, although at lower rates
than the tissue culture control surface (5400 300 cells cm2
on PCL and 10 000 2000 cells cm2 on 1% PCl/rGO and
19 200 700 cells cm2 on the control). Nonetheless, these
results illustrate the good biocompatibility of the composite scaf-
fold. Mohammadi et al.[154] performed in vitro MG63 cell culture
studies on electrospun PCL/GO nanofibrous scaffolds. The
authors reported that the incorporation of GO did not decrease
the biocompatibility of PCL nanofibers. On the contrary, cell
adhesion and proliferation increased over time. The results
showed the highest optical density value in PCL-GO (2 wt%)
group compared with PCL, indicating that cells on fibers with
the highest GO concentration had also the highest proliferation
rate. The observed cells exhibited the usual spreading morphol-
ogy with typical nuclei, demonstrating the suitability of the envi-
ronment for cell organization and colony formation. Moreover,
cells cultured on PCL-GO reached more confluency and broad-
ened with large areas, which confirmed that the composites pres-
ent higher cell attachment. As such, this study indicated that GO
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is favorable for the adhesion and proliferation of cells. These pos-
itive results have also been reported by other authors, such as
Wang et al.,[193] that produced PCL/pristine graphene scaffolds
for tissue-repair applications, demonstrating that the addition of
graphene had a positive impact on human adipose-derived stem
cell viability and proliferation, and such as Sayyar et al.,[194] which
also demonstrated the biocompatibility and suitability of PCL/
graphene scaffolds to support the adhesion and proliferation
of different cell lines (L929 fibroblasts, PC-12 neural cells, and
C2C12 muscle cells).
The ability to be biocompatible and biofunctional is extremely
important to guarantee the success of tissue-repair strategies. The
presented polymers are biocompatible and the addition of gra-
phene and graphene-based materials does not change that, and
sometimes even improves their biofunctionality, as demonstrated
through the previous reported in vitro studies through enhanced
adhesion, proliferation, andmetabolic activity displayed by several
cell lines, including fibroblasts, which are the main intrinsic cell
types responsible for the repair of damaged tendon and ligament
tissues and also through the enhanced healing reported in in vivo
studies. Indeed, in a recent study, Lasocka et al.[195] evaluated the
cytotoxicity of the pristine graphene monolayer and its utility as a
scaffold for fibroblast L929 cell line. The toxicity degree was
assessed based on cell morphology, viability, and mitochondrial
activity. Cell motility was evaluated using a wound-healing assay,
in which a scratch was made on a precultured cell monolayer, and
cell migration was evaluated by analyzing the cells that had
migrated into the wound area after a posterior incubation period.
Graphene was found to have no cytotoxicity on the studied fibro-
blasts and increased cell adhesion and proliferation within 24 h of
culture. During the culture period, round-shaped cells gradually
changed into a spindle form (Figure 9a). The proliferation of cells
grown on graphene was also significantly higher (113.5 3.2%)
in comparison with the control group (100 3.8%) (Figure 9b).
Furthermore, “wound” closure in the graphene experimental
group occurred as a result of linear, regular, and organized cell
migration through the pristine scaffold, originating from both
edges of the scratch, whereas in the control group (glass sub-
strate), this migration was less organized. After complete closure
of the “wound” took place, there were no significant differences in
the mean area of fibroblasts migrating into the scratch, although
cells on the graphene substrate presented a slightly larger area.
All the earlier findings combined suggested that graphene
could be beneficial for damaged tissue recovery, having the poten-
tial to support and even improve the healing capacity of damaged
tendons and ligaments. Overall, these fillers have shown to not
cause cytotoxicity in small studies. As a result, they are being con-
templated with optimism in terms of their potential for biomedical
applications. However, simple cytotoxicity tests do not satisfy the
strict requirements for the translation of novel nanomaterials into
clinical use. Long-term in vivo investigations of the biocompatibil-
ity of graphene are required to fully establish its biocompatibility
and safe use for biomedical applications.[119,136,196]
6. Conclusions
Despite all the progress observed during the past years regarding
the development of a new scaffold for tendon/ligament repair,
an ideal one has not been reported yet. Among the several chal-
lenges associated with current existent solutions, the main one
remains to match the mechanical properties of the native tissues,
which is of significant importance for the achievement of a func-
tional repair.
The present Review introduces a novel strategy for tendon and
ligament repair, based on the introduction of graphene fillers
into biodegradable synthetic polymers as a potential solution
to improve their properties and allow their use in such demand-
ing applications. Results available in the literature are very
Figure 8. a) Results on proliferation and ALP activity in BC, PLGA, and PLGA/GO groups after BMSCs were seeded onto electrospun nanofibrous
membranes. b) Representative histology images of the cartilage tissue at the insertion site. Reproduced with permission.[191] Copyright 2019,
The Authors, published by Dove Medical Press Ltd.
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encouraging, with substantial improvements in mechanical
properties being reported along with their preservation for longer
periods of time. Furthermore, graphene–polymer composites
have been found to have no cytotoxicity on several cell lines
and the introduction of graphene has been proved to be benefi-
cial to enhance the healing rate of tendon and ligament tissues. It
can thus be possible to conclude that the addition of graphene
fillers can potentially improve the properties of conventional
materials and overcome the shortcomings that have been result-
ing in failure and preventing their use. If an improved biodegrad-
able material is available, a posterior adequate choice in terms of
the scaffold structure, namely regarding its final shape, size,
architecture, and porosity, can pave the way for the development
of innovative structures for tendon and ligament repair, as these
factors also influence the properties of the final device.
Therefore, these composites present a great potential to over-
come the limitations of current devices and finally improve clin-
ical outcomes.
The enormous amount of effort that has been put into gra-
phene research makes it easier to expect with optimism that gra-
phene will, at a future time, transition to an industrial level and
become a fundamental part of economic development in several
fields, including biomedicine. However, an emergent need of
more research in terms of in vivo long-term toxicity is crucial
for their use in biomedical applications and transition into the
clinic.
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